Text Size

History, presence, and future of mitomycin C in glaucoma filtration surgery

Wolters J.E.J., van Mechelen R.J.S., Al Majidi R., Pinchuk L., Webers C.A.B., Beckers H.J.M., Gorgels T.G.M.F.


  • 2021
  • Current opinion in ophthalmology
View publication
  • Therapeutic Area

    Glaucoma

  • Categories

    Post-Approval studies/RWE

  • Affiliations

    Wolters, J.E.J., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; van Mechelen, R.J.S., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Al Majidi, R., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands, School for Mental Health and Neuroscience, Maastricht University, Maastricht, Netherlands; Pinchuk, L., InnFocus, Inc., Santen Company, Ophthalmic Biophysics Center, Bascom Palmer Eye Institute, University of Miami Miller School of Medicine, Miami, FL, United States; Webers, C.A.B., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands; Beckers, H.J.M., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands; Gorgels, T.G.M.F., University Eye Clinic Maastricht, Maastricht University Medical Centre + (MUMC+), Maastricht, Netherlands, Chemelot Institute for Science and Technology (InSciTe), Geleen, Netherlands

Related Publications

Metabolomic Profiling of Open-Angle Glaucoma Etiologic Endotypes: Tohoku Multi-Omics Glaucoma Study

Hanyuda A.; Raita Y.; Ninomiya T.; Hashimoto K.; Takada N.; Sato K.; Inoue J.; Koshiba S.; Tamiya G.; Narita A.; Akiyama M.; Omodaka K.; Tsuda S.; Yokoyama Y.; Himori N.; Yamamoto Y.; Taniguchi T.; Negishi K.; Nakazawa T.


Ocular Tissue Distribution of Omidenepag Isopropyl in Rabbits and Cynomolgus Monkeys

Yamamura K.; Mano H.; Fuwa M.; Ryoiwamura; Odani-Kawabata N.


Omidenepag Isopropyl 0.002% versus Latanoprost 0.005% in Open-Angle Glaucoma/Ocular Hypertension: The Randomized Phase III PEONY Trial

Wang T.H.; Aung T.; Lu D.-W.; George R.; Senthil S.; Lu F.; Odani-Kawabata N.; Park K.H.


Can't find what you're looking for?

Contact us

Document number: NP-No product-EMEA-0110
Date of preparation: February 2022